A WORLD OF DATA DRIVEN INSIGHTS
MOgene delivers precise research and clinical insights for our customers based on decades of experience offering comprehensive, highly customized, and data-driven genomic solutions
Since 2004 MOgene has provided quality genomic services to research, biotech, pharma, and government facilities.
Our team of experts guide our customers through every step of their projects, from the complex to the routine.
We deliver quality results for both small and large projects with a convenient, one-stop solution for a wide range of services.
Since 2004, MOgene LC has provided quality genomic services to agriculture, pharmaceutical, biotechnology, and government facilities. Our extensive journal citations for our services and testimonials demonstrate our solid reputation and customer focus. We provide a convenient one-stop solution for a wide range of services and deliver quality results. From RNA/DNA isolation, microarrays, qPCR, sequencing, targeted sequence capture and bioinformatics, we’ve got your research needs covered. We stay on the cutting edge of technology platforms.
MOgene’s mission is to provide best in class services to its partners in deploying genomic capabilities to bring critical solutions to agriculture, pharmaceutical, diagnostic, and industrial biotech operations.
MOgene’s Key Management and Founders include:
Craig Morley R.Ph
is currently the CEO of MOgene, and has years of experience in both corporate and entrepreneurial settings with extensive business development, general management and P&L responsibilities. Mr. Morley has a track record of successfully managing, developing and commercializing products and services within the pharmaceutical, medical diagnostic and contract research industries having held senior level positions in companies which include: Eli Lilly, bioMérieux, Covance, Millipore, and EAG Life Sciences.
is currently the Senior Vice President of Technical and Business Development at MOgene and has vast experience in molecular biology and gene expression. Mr. Rangwala helped establish MOgene in 2004, after working nearly two decades at Monsanto, where he served as a project leader in Nutrition and gene expression, and was a part of the team whose work lead to compounds for HIV-1 protease inhibitor and arthritis medication Celebrex.
Ganesh Kishore, Ph.D
is currently the Managing Partner, Spruce Capital Partners LLC and MLS Capital Fund II. Prior to this he was Chief Biotechnology Officer at DuPont Company and formerly Chief Biotechnologist at Monsanto Company and President of its Nutrition sector. During his tenure at Monsanto, he led the efforts on discovery, development and commercialization of transgenic traits and at Dupont; he spearheaded the development of a broad based, integrated biotech strategy in the area of seeds and industrial biotechnology.
Rajeev Aurora, Ph.D
is an Associate Professor in the Department of Molecular Microbiology & Immunology, Saint Louis University School of Medicine, Saint Louis. He was formerly a Director of Bioinformatics at Pfizer Corporation.
Himadri Pakrasi, Ph.D
is the Glassberg-Greensfelder Distinguished University Professor at Washington University. He is also the Director of the University’s International Center for Energy, Environment and Sustainability.
Ralph S. Quatrano, Ph.D.
is the past Spencer T. Olin Professor of Biology in the School of Arts and Sciences. He was formerly the Chairman of the Department of Biology, Director of the Division of Biology and Biomedical Sciences and Dean of Arts & Sciences and Engineering and Applied Sciences at Washington University in St. Louis.
OUR HISTORY SPEAKS FOR ITSELF
Supporting Genomic Studies Since 2004
Industry Leading Experienced Team
More Than 150 Citations in Peer-reviewed Journals
To contact MOgene or request a quote click the links below